Literature DB >> 6366557

Current concepts. Primary sclerosing cholangitis.

N F LaRusso, R H Wiesner, J Ludwig, R L MacCarty.   

Abstract

Primary sclerosing cholangitis is a progressive, ultimately fatal, chronic hepatobiliary disorder for which no effective medical or surgical therapy now exists. The syndrome occurs most commonly in young men and is characterized by a chronic cholestatic syndrome, frequent association with chronic ulcerative colitis, hepatic copper overload, a paucity of serologic markers, and characteristic abnormalities in some liver-biopsy specimens and most cholangiograms. The natural history of the syndrome is unclear; the disease is likely to progress slowly and relentlessly, over a decade or longer, from an asymptomatic stage to a condition characterized by symptoms of cholestasis and complicated by cirrhosis, portal hypertension, and possibly carcinoma of the bile ducts. Screening techniques based on automated biochemical analyses are likely to lead to a diagnosis of primary sclerosing cholangitis in increasing numbers of patients, perhaps in the early, preicteric stage. An increased level of serum alkaline phosphatase in a young man, particularly if he has chronic ulcerative colitis, should strongly suggest the presence of this syndrome and the need for additional diagnostic studies. Endoscopic retrograde cholangiography and liver biopsy should be considered under these circumstances.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6366557     DOI: 10.1056/NEJM198404053101407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  71 in total

1.  Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?

Authors:  Alnoor Ramji; David A Owen; Siegfried R Erb; Charles H Scudamore; Eric M Yoshida
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.

Authors:  Takashi Himoto; Hirohito Yoneyama; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Reiji Haba; Seishiro Watanabe; Shoichi Senda; Tsutomu Masaki
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

3.  Surgical aspects of sclerosing cholangitis. Results in 178 patients.

Authors:  F M Martin; R L Rossi; F W Nugent; F J Scholz; R L Jenkins; W D Lewis; M Gagner; E Foley; J W Braasch
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

4.  Sonographic diagnosis of cholangitis in AIDS patients.

Authors:  D Defalque; Y Menu; P M Girard; J P Coulaud
Journal:  Gastrointest Radiol       Date:  1989

5.  Primary sclerosing cholangitis in India.

Authors:  S K Acharya; S Vashisht; R K Tandon
Journal:  Gastroenterol Jpn       Date:  1989-02

6.  [Rare initial manifestation and differential diagnosis of primary sclerosing cholangitis].

Authors:  B Rehermann; K Klugewitz; U Seifert; K H Böker; S Wagner; M P Manns
Journal:  Med Klin (Munich)       Date:  1997-07-15

7.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  F Seibold; P Weber; R Klein; P A Berg; K H Wiedmann
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease.

Authors:  Tim O Hirche; Jan Russler; Barbara Braden; Gudrun Schuessler; Stefan Zeuzem; Till Wehrmann; Hans Seifert; Christoph F Dietrich
Journal:  Int J Colorectal Dis       Date:  2004-04-15       Impact factor: 2.571

10.  Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.

Authors:  Masanori Koyabu; Kazushige Uchida; Hideaki Miyoshi; Yutaku Sakaguchi; Toshiro Fukui; Hiroki Ikeda; Makoto Takaoka; Junko Hirohara; Akiyoshi Nishio; Yoshiko Uemura; Shinji Uemoto; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-01-20       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.